Oxford Nanopore Technologies Limited
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hard… Read more
Market Cap & Net Worth: Oxford Nanopore Technologies Limited (ONTTF)
Oxford Nanopore Technologies Limited (PINK:ONTTF) has a market capitalization of $1.24 Billion ($1.24 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #10178 globally and #4758 in its home market, demonstrating a -18.47% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oxford Nanopore Technologies Limited's stock price $1.28 by its total outstanding shares 966907658 (966.91 Million).
Oxford Nanopore Technologies Limited Market Cap History: 2021 to 2025
Oxford Nanopore Technologies Limited's market capitalization history from 2021 to 2025. Data shows change from $9.43 Billion to $1.24 Billion (-42.19% CAGR).
Oxford Nanopore Technologies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oxford Nanopore Technologies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
10.98x
Oxford Nanopore Technologies Limited's market cap is 10.98 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $9.43 Billion | $133.66 Million | -$167.61 Million | 70.53x | N/A |
| 2022 | $2.91 Billion | $198.60 Million | -$91.03 Million | 14.63x | N/A |
| 2023 | $2.51 Billion | $169.67 Million | -$154.51 Million | 14.82x | N/A |
| 2024 | $2.01 Billion | $183.19 Million | -$146.19 Million | 10.98x | N/A |
Competitor Companies of ONTTF by Market Capitalization
Companies near Oxford Nanopore Technologies Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Oxford Nanopore Technologies Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Oxford Nanopore Technologies Limited Historical Marketcap From 2021 to 2025
Between 2021 and today, Oxford Nanopore Technologies Limited's market cap moved from $9.43 Billion to $ 1.24 Billion, with a yearly change of -42.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.24 Billion | -38.46% |
| 2024 | $2.01 Billion | -20.00% |
| 2023 | $2.51 Billion | -13.48% |
| 2022 | $2.91 Billion | -69.18% |
| 2021 | $9.43 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Oxford Nanopore Technologies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.24 Billion USD |
| MoneyControl | $1.24 Billion USD |
| MarketWatch | $1.24 Billion USD |
| marketcap.company | $1.24 Billion USD |
| Reuters | $1.24 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.